Outcome and Prognostic Factors of High-Risk Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation

BACKGROUND Allogeneic transplantation remains one of the best therapies for high-risk acute myeloid leukemia (HR-AML). MATERIAL AND METHODS This study retrospectively analyzed 126 patients with HR-AML after allogeneic hematopoietic stem cell transplantation (allo-HCST). RESULTS The disease-free surv...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Annals of Transplantation 2019-06, Vol.24, p.328-340
Hauptverfasser:	Zhu, Cheng-Ying, Chen, Guo-Feng, Zhou, Wei, Hou, Cheng, Wang, Xiao-Kai, Wang, Fei-Yan, Yang, Nan, Wang, Li, Fang, Shu, Luo, Lan, Guan, Li-Xun, Zhang, Ran, Liu, Yu-Chen, Dou, Li-Ping, Gao, Chun-Ji
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Disease-Free Survival Female Hematopoietic Stem Cell Transplantation - mortality Humans Leukemia, Myeloid, Acute - mortality Leukemia, Myeloid, Acute - surgery Male Middle Aged Original Paper Prognosis Recurrence Retrospective Studies Survival Rate Transplantation, Homologous Treatment Outcome Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!